Loss of Mrap2 is associated with Sim1 deficiency and increased circulating cholesterol

Article


Novoselova, T., Larder, R., Rimmington, D., Lelliot, C., Wynn, E., Gorrigan, R., Tate, P., Guasti, L., The Sanger Mouse Genetics Project, O'Rahilly, S., Clark, A., Logan, D., Coll, A. and Chan, L. 2016. Loss of Mrap2 is associated with Sim1 deficiency and increased circulating cholesterol. Journal of Endocrinology. 230 (1), pp. 13-26. https://doi.org/10.1530/JOE-16-0057
TypeArticle
TitleLoss of Mrap2 is associated with Sim1 deficiency and increased circulating cholesterol
AuthorsNovoselova, T., Larder, R., Rimmington, D., Lelliot, C., Wynn, E., Gorrigan, R., Tate, P., Guasti, L., The Sanger Mouse Genetics Project, O'Rahilly, S., Clark, A., Logan, D., Coll, A. and Chan, L.
Abstract

Melanocortin receptor accessory protein 2 (MRAP2) is a transmembrane accessory protein predominantly expressed in the brain. Both global and brain-specific deletion of Mrap2 in mice results in severe obesity. Loss-of-function MRAP2 mutations have also been associated with obesity in humans. Although MRAP2 has been shown to interact with MC4R, a G protein-coupled receptor with an established role in energy homeostasis, appetite regulation and lipid metabolism, the mechanisms through which loss of MRAP2 causes obesity remains uncertain. In this study, we used two independently derived lines of Mrap2 deficient mice (Mrap2tm1a/tm1a) to further study the role of Mrap2 in the regulation of energy balance and peripheral lipid metabolism. Mrap2tm1a/tm1a mice have a significant increase in body weight, with increased fat and lean mass, but without detectable changes in food intake or energy expenditure. Transcriptomic analysis showed significantly decreased expression of Sim1, Trh, Oxt and Crh within the hypothalamic paraventricular nucleus of Mrap2tm1a/tm1a mice. Circulating levels of both high-density lipoprotein and low-density lipoprotein were significantly increased in Mrap2 deficient mice. Taken together, these data corroborate the role of MRAP2 in metabolic regulation and indicate that, at least in part, this may be due to defective central melanocortin signalling

PublisherSociety for Endocrinology
JournalJournal of Endocrinology
ISSN0022-0795
Electronic1479-6805
Publication dates
Online01 Jul 2016
Print01 Jul 2016
Publication process dates
Deposited12 Nov 2019
Accepted21 Apr 2016
Output statusPublished
Publisher's version
Copyright Statement

© 2016 Society for Endocrinology. Printed in Great Britain. Published by Bioscientifica Ltd.
This work is licensed under a Creative Commons Attribution 3.0 Unported License

Digital Object Identifier (DOI)https://doi.org/10.1530/JOE-16-0057
LanguageEnglish
Permalink -

https://repository.mdx.ac.uk/item/88950

  • 25
    total views
  • 15
    total downloads
  • 0
    views this month
  • 0
    downloads this month

Export as